IMRX
#3260
Immuneering Corporation - Class A Common Stock
4.9 9 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.22%
Monthly Change
+22.00%
6 month change
+2.89%
Year Change
-11.52%
Previous Close
5.2 1
Open
4.9 9
Low
4.9 9
High
4.9 9
Volume
41
Financials
- Market Capitalization 322.84 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.18
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3219 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.92 USD | -1.99% | -3.43% | -5.43% | -13.45% | 338.53 M USD | ||
| 3222 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +9.05% | +36.16% | 336.28 M USD | ||
| 3264 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.29 USD | -2.76% | -0.94% | +4.13% | -4.34% | 319.85 M USD | ||
| 3295 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +35.51% | +92.22% | 311.95 M USD |
Frequently asked questions about Immuneering Corporation Class A Common Stock
What is the Immuneering Corporation Class A Common Stock stock price today?
The current price of Immuneering Corporation Class A Common Stock (IMRX) is 4.99. Over the past 24 hours, the stock has changed by -4.22%. Follow the IMRX chart for real-time price dynamics.
What is the stock ticker of Immuneering Corporation Class A Common Stock?
Immuneering Corporation Class A Common Stock trades under the ticker IMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immuneering Corporation Class A Common Stock stock going up?
IMRX has changed by -5.67% over the last week, +22.00% over the last month, and -11.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immuneering Corporation Class A Common Stock?
Immuneering Corporation Class A Common Stock currently has a market capitalization of 322.84 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immuneering Corporation Class A Common Stock earnings last quarter?
Last quarter, Immuneering Corporation Class A Common Stock reported earnings of -0.27 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immuneering Corporation Class A Common Stock net income for the last quarter?
Immuneering Corporation Class A Common Stock reported net income of -17.27 M for the last quarter. The previous quarter showed -13.46 M, which means net income changed by -28.30%.
How many employees does Immuneering Corporation Class A Common Stock have?
As of the latest available data, Immuneering Corporation Class A Common Stock has 57 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immuneering Corporation Class A Common Stock stock?
You can buy Immuneering Corporation Class A Common Stock (IMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immuneering Corporation Class A Common Stock stock?
Investing in Immuneering Corporation Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMRX chart and related analysis on metatrader.com as part of your research.